2023 Form 5500 filing — Recipharm Laboratories, Inc. 401(K) Plan
Plain-English filing summary
According to public Form 5500 filings published through the U.S. Department of Labor (DOL) Employee Benefits Security Administration (EBSA) via the EFAST2 system, this is the 2023 Form 5500 filing (EFAST2 acknowledgement 20241015124846NAL0047980832001) for Recipharm Laboratories, Inc. 401(K) Plan, reported by Recipharm Laboratories, Inc. under EIN 56-2041552 and plan number 001. It reports 345 participants. Attached schedules in the loaded dataset include Schedule H (large plan financials), Schedule C (service provider compensation).
- EFAST2 acknowledgement
- 20241015124846NAL0047980832001
- Filing year
- 2023
- Form type
- 2
- Plan sponsor
- Recipharm Laboratories, Inc.
- EIN
- 56-2041552
- Plan number
- 001
- Location
- Research Triangle Pk, NC
- Participants
- 345
- Schedules available
- Schedule H, Schedule C
- Received date
- not reported in the loaded dataset
Reported financial snapshot (2023)
- Total assets (EOY)
- $15,037,768
- Total liabilities (EOY)
- $0
- Net assets (EOY)
- $15,037,768
- Employer contributions
- $1,800,209
- Participant contributions
- $2,609,874
- Total income / additions
- $7,323,409
- Benefits paid
- $974,835
- Administrative expenses
- $54,414
- Total expenses
- $1,029,249
- Net increase / (decrease)
- $6,294,160
- Schedule source
- Schedule H
Reported service provider compensation (Schedule C)
| Provider | Service | Direct comp. | Indirect comp. |
|---|---|---|---|
| Fidelity Management Trust Company | PLAN ADMINISTRATOR | $54,414 | $0 |